icu

肺炎治疗最新观念

Management of Pneumonia: Are You Really Up to Date?
Disclosures
Henry Masur, MD
Introduction
At the 32nd Critical Care Congress in San Antonio, Texas, management of pneumonia was an important topic of discussion. A panel of experts discussed current concepts of pneumonia management, focusing on therapy and prevention.
　　Prevention of Ventilator-Associated Pneumonia
　　Do Anaerobes Really Cause Pneumonia?
　　Continuous Dosing of Antibiotics for Pneumonia
　　Use of Combination Therapy in Pneumonia
References
1. Kollef MH. Infection: pneumonia. Cutting edge strategies for the prevention of ventilator-associated pneumonia. Program and abstracts of the 32nd Critical Care Congress; January 28-February 2, 2003; San Antonio, Texas.
2. Shorr AF, O'Malley PG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: Potential economic implications. Chest. 2001;119:228-235.
3. Prince AS. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med. 2002;347:1110-1111.
4. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877.
5. Giles FJ, Redman R, Yazji S, Bellm L. Iseganan HCl: a novel antimicrobial agent. Expert Opin Investig Drugs. 2002;11:1161-1170.
6. Marik P. Infection: pneumonia. Is it necessary to provide coverage against obligate anaerobes? Program and abstracts of the 32nd Critical Care Congress; January 28-February 2, 2003; San Antonio, Texas.
7. Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis. 1979;119:19-23.
8. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis. 1993;16(suppl 4):S248-S255.
9. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest. 1999;115:178-183.
10. Nicolau DP. Infection: pneumonia. Continuous versus intermittent dosing of beta-lactam antibiotics for pneumonia. Program and abstracts of the 32nd Critical Care Congress; January 28-February 2, 2003; San Antonio, Texas.
11. Kuti JL, Nightingale CH, Quintiliani R, Nicolau DP. Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis. Diagn Microbiol Infect Dis. 2002;44:51-57.
12. Wunderink RG. Infection: pneumonia. Single versus double agent coverage. Program and abstracts of the 32nd Critical Care Congress; January 28-February 2, 2003; San Antonio, Texas.
13. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med. 2001;161:1837-1842.
14. Mitchell LS, Tuomanen EI. Molecular analysis of antibiotic tolerance in pneumococci. Int J Med Microbiol. 2002;292:75-79.